MPS Ltd — earnings calls
2 quarters summarised from transcripts filed with the exchange, every statement cited. Newest first.
MPS Limited reported Q1 FY'27 revenue of INR 224.24 crores, up 20.4% year over year, with EBITDA up 53.0% to INR 76.96 crores and EBITDA margin expanding to 34.3% from 27.0%. Management said all three segments grew, with Research Solutions, Education, and Corporate Learning each showing margin expansion, while Corporate Learning posted its second consecutive quarter of growth. Management reaffirmed the FY'27 outlook to comfortably cross INR 300 crores in EBITDA and discussed the Unbound Medicine acquisition, AI adoption across segments, and a shift toward outcomes-based revenue.
MPS Limited reported FY26 group revenue of INR 768 crores, up 5.7% year-on-year, with EBITDA of INR 236 crores and profit after tax of INR 173 crores, both records for the company. Q4 FY26 revenue grew 12.7% year-on-year to INR 205 crores with EBITDA margin expanding to 32.9%. Management guided to crossing INR 300 crores in EBITDA for FY27 and discussed progress in the Research, Education, and Corporate Learning segments along with the recently closed Unbound Medicine acquisition.